Company: IMRX
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001790340-25-000061
Chunk: 317

Company: Immuneering Corp
Filing Date: 2025-05-05
Form: 10-Q
Item: Part II, Item 3
Chunk 317
---
 Inline XBRL and contained in Exhibit 101)*

*    Filed herewith.

**    Furnished herewith.

#    Indicates management contract or compensatory plan.

91

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized. 

IMMUNEERING CORPORATIONDate: May 5, 2025By:/s/ Benjamin J. ZeskindName:Benjamin J. Zeskind, Ph.D.Title:Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer)Date: May 5, 2025By:/s/ Mallory MoralesName:Mallory MoralesTitle:Chief Accounting Officer and Treasurer(Principal Financial Officer and Principal Accounting Officer)

92